{"paper_id":"d75e202a-8964-41c9-bbe3-4bd06050e4f4","body_text":"The Role of miRNA Let-7a-1 and Let-7f-1 in Regulating Inflammatory and Angiogenic Pathways in Endometriosis\nDOI:\nhttps://doi.org/10.52783/jns.v14.1590Keywords:\nendometriosis, miRNA let-7a-1, miRNA let-7f-1, biomarkers, molecular therapyAbstract\nBackground\nEndometriosis, a chronic gynecological disorder characterized by the ectopic growth of endometrial tissue, involves complex inflammatory and angiogenic mechanisms. MicroRNAs (miRNAs), particularly Let-7a-1 and Let-7f-1, have been identified as key regulators of these pathways, influencing the progression and symptoms of the disease.\nObjectives\nThis review aims to explore the roles of miRNA Let-7a-1 and Let-7f-1 in the regulation of inflammatory and angiogenic pathways in endometriosis, highlighting their potential as biomarkers and therapeutic targets.\nMaterials and Methods\nA comprehensive literature search was conducted using databases such as PubMed, Scopus, and Web of Science. Relevant studies published between 2000 and 2024 were included, focusing on the expression, function, and regulatory mechanisms of Let-7a-1 and Let-7f-1 in endometriosis. Key findings were synthesized to provide an updated understanding of their biological and clinical relevance.\nResults\nEvidence indicates that Let-7a-1 and Let-7f-1 play pivotal roles in modulating pro-inflammatory cytokines, angiogenic factors like VEGF, and cellular proliferation in endometriotic lesions. Dysregulated expression of these miRNAs is associated with enhanced inflammatory responses and aberrant angiogenesis, contributing to the persistence and progression of endometriosis. Furthermore, preclinical studies demonstrate that targeting Let-7 family miRNAs can mitigate these processes, suggesting their potential utility in therapeutic strategies.\nConclusion\nLet-7a-1 and Let-7f-1 serve as critical modulators in the inflammatory and angiogenic pathways of endometriosis, offering insights into disease pathophysiology. Their roles as biomarkers and therapeutic targets warrant further investigation, paving the way for novel diagnostic and treatment approaches in endometriosis management.\nDownloads\nReferences\nBendifallah S, Dabi Y, Suisse S, et al. A Bioinformatics Approach to MicroRNA-Sequencing Analysis Based on Human Saliva Samples of Patients with Endometriosis. IJMS. 2022;23(14):8045. doi:10.3390/ijms23148045\nLeonova A, Turpin VE, Agarwal SK, Leonardi M, Foster WG. A critical appraisal of the circulating levels of differentially expressed microRNA in endometriosis. Biology of Reproduction. 2021;105(5):1075-1085. doi:10.1093/biolre/ioab134\nFebriza A, Hatta M, Natzir R, Kasim VNA, Idrus HH. Activity of Antimicrobial Peptide; Cathelicidin, on Bacterial Infection. TOBIOCJ. 2019;13(1):45-53. doi:10.2174/1874091X01913010045\nAntonio LGL, Meola J, Rosa-e-Silva ACJDS, et al. Altered Differential Expression of Genes and microRNAs Related to Adhesion and Apoptosis Pathways in Patients with Different Phenotypes of Endometriosis. IJMS. 2023;24(5):4434. doi:10.3390/ijms24054434\nBrulport A, Bourdon M, Vaiman D, et al. An integrated multi-tissue approach for endometriosis candidate biomarkers: a systematic review. Reprod Biol Endocrinol. 2024;22(1):21. doi:10.1186/s12958-023-01181-8\nZubrzycka A, Migdalska-Sęk M, Jędrzejczyk S, Brzeziańska-Lasota E. Assessment of BMP7, SMAD4, and CDH1 Expression Profile and Regulatory miRNA-542-3p in Eutopic and Ectopic Endometrium of Women with Endometriosis. IJMS. 2023;24(7):6637. doi:10.3390/ijms24076637\nAnastasiu CV, Moga MA, Elena Neculau A, et al. Biomarkers for the Noninvasive Diagnosis of Endometriosis: State of the Art and Future Perspectives. IJMS. 2020;21(5):1750. doi:10.3390/ijms21051750\nNothnick WB, Al-Hendy A, Lue JR. Circulating Micro-RNAs as Diagnostic Biomarkers for Endometriosis: Privation and Promise. Journal of Minimally Invasive Gynecology. 2015;22(5):719-726. doi:10.1016/j.jmig.2015.02.021\nZubrzycka A, Migdalska-Sęk M, Jędrzejczyk S, Brzeziańska-Lasota E. Circulating miRNAs Related to Epithelial–Mesenchymal Transitions (EMT) as the New Molecular Markers in Endometriosis. CIMB. 2021;43(2):900-916. doi:10.3390/cimb43020064\nWu J, Fang X, Huang H, Huang W, Wang L, Xia X. Construction and topological analysis of an endometriosis-related exosomal circRNA-miRNA-mRNA regulatory network. Aging. 2021;13(9):12607-12630. doi:10.18632/aging.202937\nFebriza A, Natzir R, Hatta M, Alam G, Kasim VN, Idrus HH. Curcumin effects in inducing mRNA gene cathelidicin antimicrobial peptide in Balb/c mice infected with Salmonella typhi.\nTian Z, Chang XH, Zhao Y, Zhu HL. Current biomarkers for the detection of endometriosis. Chinese Medical Journal. 2020;133(19):2346-2352. doi:10.1097/CM9.0000000000001063\nChen G, Guo J, Li W, Zheng R, Shang H, Wang Y. Diagnostic value of the combination of circulating serum miRNAs and CA125 in endometriosis. Medicine. 2023;102(48):e36339. doi:10.1097/MD.0000000000036339\nKasim V, Hatta M, Natzir R, Hadju V, Febriza A, Idrus H. Effects of lime (Citrus aurantifolia) peel to the expression of mRNA toll-like receptors 4 in balb/c mice-infected Salmonella typhi. J Adv Pharm Technol Res. 2020;11(4):169. doi:10.4103/japtr.JAPTR_48_20\nCosar E, Mamillapalli R, Moridi I, Duleba A, Taylor HS. Serum MicroRNA Biomarkers Regulated by Simvastatin in a Primate Model of Endometriosis. Reprod Sci. 2019;26(10):1343-1350. doi:10.1177/1933719118765971\nGiudice LC, Oskotsky TT, Falako S, Opoku‐Anane J, Sirota M. Endometriosis in the era of precision medicine and impact on sexual and reproductive health across the lifespan and in diverse populations. The FASEB Journal. 2023;37(9):e23130. doi:10.1096/fj.202300907\nSteinbuch SC, Lüß AM, Eltrop S, Götte M, Kiesel L. Endometriosis-Associated Ovarian Cancer: From Molecular Pathologies to Clinical Relevance. IJMS. 2024;25(8):4306. doi:10.3390/ijms25084306\nWu Y, Yuan W, Ding H, Wu X. Serum exosomal miRNA from endometriosis patients correlates with disease severity. Arch Gynecol Obstet. 2022;305(1):117-127. doi:10.1007/s00404-021-06227-z\nZubrzycka A, Migdalska-Sęk M, Jędrzejczyk S, Brzeziańska-Lasota E. The Expression of TGF-β1, SMAD3, ILK and miRNA-21 in the Ectopic and Eutopic Endometrium of Women with Endometriosis. IJMS. 2023;24(3):2453. doi:10.3390/ijms24032453\nSunarno S, Puspandari N, Fitriana F, Nikmah UA, Idrus HH, Panjaitan NSD. Extended spectrum beta lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae in Indonesia and South East Asian countries: GLASS Data 2018. AIMSMICRO. 2023;9(2):218-227. doi:10.3934/microbiol.2023013\nOchoa Bernal MA, Fazleabas AT. The Known, the Unknown and the Future of the Pathophysiology of Endometriosis. IJMS. 2024;25(11):5815. doi:10.3390/ijms25115815\nBrinca AT, Peiró AM, Evangelio PM, et al. Follicular Fluid and Blood Monitorization of Infertility Biomarkers in Women with Endometriosis. IJMS. 2024;25(13):7177. doi:10.3390/ijms25137177\nAgrawal S, Tapmeier TT, Rahmioglu N, Kirtley S, Zondervan KT, Becker CM. The miRNA Mirage: How Close Are We to Finding a Non-Invasive Diagnostic Biomarker in Endometriosis? A Systematic Review. IJMS. 2018;19(2):599. doi:10.3390/ijms19020599\nZhang L, Li H, Yuan M, Li D, Sun C, Wang G. Serum Exosomal MicroRNAs as Potential Circulating Biomarkers for Endometriosis. Disease Markers. 2020;2020:1-10. doi:10.1155/2020/2456340\nPerricos A, Proestling K, Husslein H, et al. Hsa-mir-135a Shows Potential as A Putative Diagnostic Biomarker in Saliva and Plasma for Endometriosis. Biomolecules. 2022;12(8):1144. doi:10.3390/biom12081144\nNazri HM, Greaves E, Quenby S, Dragovic R, Tapmeier TT, Becker CM. The role of small extracellular vesicle-miRNAs in endometriosis. Human Reproduction. 2023;38(12):2296-2311. doi:10.1093/humrep/dead216\nChico-Sordo L, Ruiz-Martínez T, Toribio M, et al. Identification of miR-30c-5p microRNA in Serum as a Candidate Biomarker to Diagnose Endometriosis. IJMS. 2024;25(3):1853. doi:10.3390/ijms25031853\nKumari P, Sharma I, Saha SC, Srinivasan R, Bhardwaj P. Role of serum microRNAs as biomarkers for endometriosis, endometrioid carcinoma of ovary & endometrioid endometrial cancer. Indian Journal of Medical Research. 2022;156(3):516-523. doi:10.4103/ijmr.IJMR_288_20\nCollins KE, Wang X, Klymenko Y, et al. Transcriptomic analyses of ovarian clear-cell carcinoma with concurrent endometriosis. Front Endocrinol. 2023;14:1162786. doi:10.3389/fendo.2023.1162786\nHosseini M, Hammami B, Kazemi M. Identification of potential diagnostic biomarkers and therapeutic targets for endometriosis based on bioinformatics and machine learning analysis. J Assist Reprod Genet. 2023;40(10):2439-2451. doi:10.1007/s10815-023-02903-y\nMarí-Alexandre J, Carcelén AP, Agababyan C, et al. Interplay Between MicroRNAs and Oxidative Stress in Ovarian Conditions with a Focus on Ovarian Cancer and Endometriosis. IJMS. 2019;20(21):5322. doi:10.3390/ijms20215322\nWright KR, Mitchell B, Santanam N. Redox regulation of microRNAs in endometriosis-associated pain. Redox Biology. 2017;12:956-966. doi:10.1016/j.redox.2017.04.037\nRonsini C, Fumiento P, Iavarone I, Greco PF, Cobellis L, De Franciscis P. Liquid Biopsy in Endometriosis: A Systematic Review. IJMS. 2023;24(7):6116. doi:10.3390/ijms24076116\nVanhie A, O D, Peterse D, et al. Plasma miRNAs as biomarkers for endometriosis. Human Reproduction. 2019;34(9):1650-1660. doi:10.1093/humrep/dez116\nLi X, Zhang W, Fu J, et al. MicroRNA-451 is downregulated in the follicular fluid of women with endometriosis and influences mouse and human embryonic potential. Reprod Biol Endocrinol. 2019;17(1):96. doi:10.1186/s12958-019-0538-z\nMonnaka VU, Hernandes C, Heller D, Podgaec S. Overview of miRNAs for the non-invasive diagnosis of endometriosis: evidence, challenges and strategies. A systematic review. Einstein (São Paulo). 2021;19:eRW5704. doi:10.31744/einstein_journal/2021RW5704\nNothnick WB. MicroRNAs and Progesterone Receptor Signaling in Endometriosis Pathophysiology. Cells. 2022;11(7):1096. doi:10.3390/cells11071096\nChico-Sordo L, García-Velasco JA. MicroRNAs as Biomarkers and Therapeutic Targets in Female Infertility. IJMS. 2024;25(23):12979. doi:10.3390/ijms252312979\nMarí-Alexandre J, Sánchez-Izquierdo D, Gilabert-Estellés J, Barceló-Molina M, Braza-Boïls A, Sandoval J. miRNAs Regulation and Its Role as Biomarkers in Endometriosis. IJMS. 2016;17(1):93. doi:10.3390/ijms17010093\nBjorkman S, Taylor HS. MicroRNAs in endometriosis: biological function and emerging biomarker candidates†. Critchley HO, ed. Biology of Reproduction. 2019;101(6):1167-1178. doi:10.1093/biolre/ioz014\nHon JX, Wahab NA, Karim AKA, Mokhtar NM, Mokhtar MH. MicroRNAs in Endometriosis: Insights into Inflammation and Progesterone Resistance. IJMS. 2023;24(19):15001. doi:10.3390/ijms241915001\nBendifallah S, Dabi Y, Suisse S, et al. MicroRNome analysis generates a blood-based signature for endometriosis. Sci Rep. 2022;12(1):4051. doi:10.1038/s41598-022-07771-7\nSzubert M, Nowak-Glück A, Domańska-Senderowska D, et al. miRNA Expression Profiles in Ovarian Endometriosis and Two Types of Ovarian Cancer—Endometriosis-Associated Ovarian Cancer and High-Grade Ovarian Cancer. IJMS. 2023;24(24):17470. doi:10.3390/ijms242417470\nDownloads\nPublished\nHow to Cite\nIssue\nSection\nLicense\nThis work is licensed under a Creative Commons Attribution 4.0 International License.\nYou are free to:\n- Share — copy and redistribute the material in any medium or format\n- Adapt — remix, transform, and build upon the material for any purpose, even commercially.\nTerms:\n- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.\n- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.","source_license":"CC0","license_restricted":false}